BRANDT Inc. on May 8 announced that it has restructured its Discovery & Innovation LLC operating company, effective immediately, to give it a broader, global mandate.
Going forward, D&I will sit alongside BRANDT’s revenue-generating units and have dotted line responsibility for research and development efforts with BRANDT Europe and BRANDT South America, in addition to its traditional role as BRANDT’s innovation engine for the US domestic market.
Brian Haschemeyer will continue to lead D&I as Vice President. He will now, however, report to the newly formed BRANDT Executive Team in Tampa. Since BRANDT’s global restructuring in 2020, D&I had been a part of BRANDT Specialty Formulations group under Executive Vice President Bill Engel.
As part of the restructure, BRANDT’s US regulatory team will move into D&I. Stephanie Brenden, Director of US regulatory, will report to Haschemeyer.
“D&I is the lifeblood of our global organization,” said BRANDT President and CEO Rick Brandt. “This move recognizes the great job that Brian has been doing. Going forward, he and his team will be able to look across the entire BRANDT product development portfolio and help bring the best ideas and products to market, no matter where they are discovered or developed.”
D&I will be moving to its permanent home at the Evelyn Brandt Thomas Innovation Center in Pleasant Plains, Ill., later this summer. The unit is responsible for product discovery, field trialing and testing, product registration support, field technical support, and formulation quality control. The company said the structural change will ensure that all BRANDT’s formulations, labs, field trials, and quality controls are held to the same high global standards.